Blackmores Limited (BKL) - Research

$84.650 0.02 (0.02%)

BKL General Information +

ASX Code BKL
Website http://www.blackmores.com.au
GICS Sub-Industry Personal Products
Market Cap ($M) 1,472
Current Price $84.650
Day High $85.400
Day Low $83.580
Last Close $84.630
Price Movement $0.02 ( 0.02% )
Prices as at 16:40, 20 Sep 2019
+Security prices are delayed by at least 20 minutes and are indicative only.

Recommendation


Blackmores Limited (BKL)
BUY
below
HOLD
up to
SELL
above
Current Price
$84.650 as at 16:40, 20 Sep 2019

Price at review
$84.650 on 19 Aug 19

Max Portfolio Weighting

Business Risk

Share Price Risk

BKL Related Research

BKL Company Overview

Business Description

Blackmores Limited (BKL) is natural health company engaged in development, and sales and marketing of health products for humans and animals. It combines traditional naturopathic expertise with scientific research. Their products include vitamins, herbal and mineral nutritional supplements. Products are distributed through retail pharmacies, supermarkets, health food stores, mass merchants and distributors. BKL operates in Australia, New Zealand and Asia.

BKL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2021 F 65.54 377.64 9.20% 22.42 283.21 3.35% 100.0%
2020 F 59.93 345.90 12.00% 24.47 259.42 3.06% 100.0%
2019 A 53.43 308.93 -27.20% 38.43 220.00 1.85% 100.0%

BKL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2019 A 2020 F 2021 F 2019 A 2020 F 2021 F 2019 A 2020 F 2021 F
Asaleo Care (AHY) $565M -0.2688 -0.1852 0.1731 14.8148 18.1818 15.4993 0.00% 0.00% 5.31%
Blackmores (BKL) $1,472M -0.2152 0.0086 0.1425 26.5789 26.3514 23.0643 2.60% 2.82% 3.23%
BWX (BWX) $450M -0.5748 2.4803 0.0808 40.7199 11.7001 10.8254 0.75% 3.73% 4.56%

BKL Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.81 26.50 7.09 3.61
Market 0.86 16.80 1.61 1.83
Sector 0.65 23.40 2.05 1.94

BKL Directors

Name Position Start Date
Mr Marcus Charles Blackmore Executive Director, Interim Chief Executive Officer 27 Oct 1973
Mr Alastair Symington Managing Director 16 Sep 2019
Ms Christine Francis Holman Non-Executive Director 18 Mar 2019
Mr David Ansell Non-Executive Director 22 Oct 2013
Mr John Armstrong Non-Executive Director 5 May 2015
Mr Brent Wallace Non-Executive Director, Non-Executive Chairman 19 Oct 2005

BKL Management

Name Position
Aaron Canning Chief Financial Officer,Company Secretary
Cecile Cooper Company Secretary

BKL Substantial Shareholders

Holding Name
4,010,043 (23.10%) Blackmore, Marcus Charles

BKL Calendar of Events

Date Event
13 August 2020 Report (Annual)
13 August 2020 Report (Prelim)
18 February 2020 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.